Swiss buyout firm Partners Group has acquired a majority stake in FairJourney Biologics, a biotechnology company valued at approximately €900 million. FairJourney Biologics is known for its work in discovering novel antibody treatments for drugmakers, including Johnson & Johnson. This deal marks a significant investment in the healthcare and life sciences sectors.
Swiss buyout firm Partners Group lands deal for stake in €900mn biotech firm https://t.co/N9DPHXxHls
Scoop: Swiss buyout fund Partners Group has bought a majority stake in FairJourney Biologics, a biotechnology company that has helped to discover novel antibody treatments for drugmakers including Johnson & Johnson, valuing the business at about €900mn. https://t.co/ubNivo22Nr
Swiss buyout firm Partners Group lands deal for stake in €900mn biotech via @mroliverbarnes @FT #PrivateEquity https://t.co/jbFKqaa2aG
Swiss buyout firm Partners Group lands deal for stake in €900mn biotech - https://t.co/TmjBIVvgMy via @FT
Swiss buyout firm Partners Group lands deal for stake in €900mn biotech https://t.co/i01lhqTFMz #healthcare #lifesciences #financial
Swiss buyout firm Partners Group lands deal for stake in €900mn biotech https://t.co/ZRlmS6AqqP